Business Wire

Combined Shareholders’ Meeting of IPSEN S.A. Held on 30 May 2018

Jaa

Regulatory News:

The Combined Shareholders’ Meeting of Ipsen S.A. (Euronext: IPN; ADR: IPSEY), chaired by Marc de Garidel, Chairman of the Board, was held today, in the presence of the members of the Board of Directors and the Group’s Executive Management team.

The Shareholders’ Meeting approved all the resolutions submitted by the Board of Directors and in particular, the distribution of a dividend of €1.00 per share to be paid on 6 June 2018 (ex-dividend date 4 June 2018).

The Shareholders’ Meeting also approved the renewal of Ms. Anne Beaufour as a director, as well as the appointments as directors of M. Philippe Bonhomme, to replace MAYROY S.A., and of M. Paul Sekhri and M. Piet Wigerinck. The Board welcomed the newly-appointed directors.

Ms. Hélène Auriol-Potier, M. Hervé Couffin and M. Pierre Martinet did not wish to renew their mandate. The Board also noted today the resignation of M. Christophe Verot, as a director. The Board thanked them for their major contributions to the Board of Directors.

Following the Shareholders’ Meeting, the new Board of Directors is comprised of 12 members, five of whom are women.

During the Meeting, David Meek, Chief Executive Officer and Aymeric Le Chatelier, Executive Vice President, Chief Financial Officer, focused on the group strategy, highlights and financial results for 2017, and also confirmed the objectives and guidance for 2018.

About Ipsen
Ipsen is a global specialty-driven biopharmaceutical group focused on innovation and specialty care. The group develops and commercializes innovative medicines in three key therapeutic areas - Oncology, Neuroscience and Rare Diseases. Its commitment to oncology is exemplified through its growing portfolio of key therapies for prostate cancer, neuroendocrine tumors, renal cell carcinoma and pancreatic cancer. Ipsen also has a well-established Consumer Healthcare business. With total sales over €1.9 billion in 2017, Ipsen sells more than 20 drugs in over 115 countries, with a direct commercial presence in more than 30 countries. Ipsen's R&D is focused on its innovative and differentiated technological platforms located in the heart of the leading biotechnological and life sciences hubs (Paris-Saclay, France; Oxford, UK; Cambridge, US). The Group has about 5,400 employees worldwide. Ipsen is listed in Paris (Euronext: IPN) and in the United States through a Sponsored Level I American Depositary Receipt program (ADR: IPSEY). For more information on Ipsen, visit www.ipsen.com

Contact information

IPSEN
Media
Ian Weatherhead
Vice President, Corporate External Communications
+44 (0) 1753 627733
ian.weatherhead@ipsen.com
or
Financial Community
Eugenia Litz
Vice President, Investor Relations
+44 (0) 1753 627721
eugenia.litz@ipsen.com
or
Brigitte Le Guennec
Senior Manager, Global External Communications
+33 (0)1 58 33 51 17
brigitte.le.guennec@ipsen.com
or
Myriam Koutchinsky
Investor Relations Manager
+33 (0)1 58 33 51 04
myriam.koutchinsky@ipsen.com

Tietoja julkaisijasta

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Tilaa tiedotteet sähköpostiisi

Haluatko tietää asioista ensimmäisten joukossa? Kun tilaat mediatiedotteemme, saat ne sähköpostiisi välittömästi julkaisuhetkellä. Tilauksen voit halutessasi perua milloin tahansa.

Lue lisää julkaisijalta Business Wire

Medicrea Announces Eurospine 2018 Presence and Highlights a Recently Published Study Validating Its Predictive Modelling Approach for AIS Patients20.9.2018 16:07Tiedote

The Medicrea Group (Euronext Growth Paris: FR0004178572 – ALMED, PEA-PME eligible, and OTCQX: MNRTY and MNRTF), pioneering the transformation of spinal surgeries through Artificial Intelligence, predictive modeling and patient specific implants with its UNiD™ ASI (Adaptive Spine Intelligence) technology, announced today that the Company is attending the Eurospine 2018 meeting taking place in Barcelona, Spain, from September 19th to 21st, where UNiD™ LAB biomedical engineers will showcase the most recent developments of the Company’s UNiD™ ASI technology. Denys Sournac, President and Chief Executive Officer, stated, “At Eurospine 2018, our team of biomedical engineers will show attending spine surgeons how the UNiD™ASI technology answers the gap left by traditional implant manufacturers through a demonstration of the UNiD™ HUB, a software platform that fully integrates surgical planning through machine learning to generate personalized implants that are adapted to each individual patien

Seoul Semiconductor Wins LED Bulb Litigation and Pursuit of Further Enforcement Actions against LED Lighting Retailers20.9.2018 16:00Tiedote

Seoul Semiconductor (KOSDAQ:046890) (collectively with Seoul Viosys Co., Ltd., “Seoul”), a leading global innovator of LED products and technology, announced that the U.S. Federal District Court for Nevada issued a judgment in favor of Seoul against Philcor T.V. & Electronic Leasing, Inc. dba energyavenue.com (“Philcor”), a company that sells LED lighting products. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920005043/en/ Seoul Semiconductor's Key Patented Technologies (Graphic: Business Wire) Previously, Seoul filed a patent infringement lawsuit in Nevada District Court against Philcor asserting infringement of 8 LED patents. In the lawsuit, Philcor acknowledged that LED products used in the accused products were manufactured by several third party suppliers and, although previously unknown to Philcor, Philcor did not dispute that those products infringed Seoul Semiconductor’s patents. Philcor also did not dispute the

2018 Busan One Asia Festival to Take Place October 20-2820.9.2018 14:00Tiedote

BUSAN METROPOLITAN CITY announced that the Busan One Asia Festival (BOF) will be held from October 20th to 28th in Busan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920005024/en/ The Busan One Asia Festival (BOF) will be held from October 20th to 28th in Busan. BOF will open with a spectacular BOF Opening Performance on October 20th and end with the BOF Closing Performance on the 28th, both will be at the Busan Asiad Main Stadium. During the opening event, EXO, Wanna One, SEVENTEEN, NCT 127, Mamamoo, EXID, GFriend, and Celeb Five will show up and present wonderful K-POP performances. The closing event will have a colorful finale with performances by Red Velvet, NCT Dream, Favorite, Dynamic Duo and Rhythm Power. The photo is 2017 Busan One Asia Festival BOF Opening Performance. (Photo: Business Wire) BOF will open with a spectacular ‘BOF Opening Performance’ on October 20th and end with the ‘BOF Closing Performance’ on

L4MS Launches Its First Open Call for Cross-Border Application Experiments20.9.2018 13:30Tiedote

The European Project L4MS (Logistics for Manufacturing SME’s) is looking for European manufacturing SME’s and mid-caps to develop new, innovative solutions to boost their factory-floor logistic. As a Factories of the Future (FoF) project participating in I4MS (ICT for Manufacturing SMEs) and with the support of the European Union's Horizon 2020 research and innovation programme, the aim of L4MS project is to reduce the installation cost and time of mobile robots by a factor of 10. It will enable inexpensive deployment of small and flexible logistics solutions requiring no infrastructure change, no production downtime and no in-house expertise. In addition to equity-free funding, the companies will receive extensive technological support from the L4MS network. The best applicants with highest innovation potential will get access to: Matchmaking with system integrators and mobile robots manufactures, funding up to €250,000, state-of-the-art test environment within your region, mentoring

Uphold Makes Cred’s LBA Tokens Available For Purchase in 170+ Countries20.9.2018 13:00Tiedote

Uphold, the global digital money platform that has powered more than $3.5 billion in transactions across 184 countries, and Cred, the leader in crypto-backed credit, today announced the next step in their commercial relationship which will allow Uphold users access to LBA tokens on the Uphold platform. “Cred has secured more lending capital than any other lending company in the space by orders of magnitude,” said JP Thieriot, CEO of Uphold. “Our ability to offer Cred’s LBA token is another important milestone for our members since Cred is one of the fastest growing lending ecosystems in the crypto community. Uphold members will have access to fiat loans at a lower cost via the LBA token. Cred’s lending services can also provide a financial lifeline to the many ICO companies that have raised a significant amount of ETH and BTC and would like to receive a USD loan to diversify their balance sheets and avoid having to sell at diminished prices.” Cred and Uphold will offer two special arra

Ant Financial Launches Ant Financial Technology Brand with Full Suite of Technology Products and Services to Support Growth of Financial Institutions20.9.2018 12:43Tiedote

Ant Financial Services Group (“Ant Financial” or “the Company”) today announced that the Company would open up a full suite of technology products and services under a new brand, Ant Financial Technology, to support the growth of financial institutions by improving user experience and lowering costs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20180920005319/en/ Ant Financial launches Ant Financial Technology, a new brand supporting the growth of financial institutions, at ATEC 2018 in Hangzhou, China. (Photo: Business Wire) Announcing the launch of the Ant Financial Technology brand at the 2018 Ant Technology Exploration Conference (ATEC) in Hangzhou, Xi HU, Deputy CTO of Ant Financial said, “Since our establishment in 2014, Ant Financial has focused on developing cutting edge technologies to enable inclusive finance. We are pleased that our technology products and services have already been used to improve efficiency and

Uutishuoneessa voit lukea tiedotteitamme ja muuta julkaisemaamme materiaalia. Löydät sieltä niin yhteyshenkilöidemme tiedot kuin vapaasti julkaistavissa olevia kuvia ja videoita. Uutishuoneessa voit nähdä myös sosiaalisen median sisältöjä. Kaikki STT Infossa julkaistu materiaali on vapaasti median käytettävissä.

Tutustu uutishuoneeseemme